Ryan Feaver

Ryan Feaver has a strong background in leadership and collaboration within the biotechnology industry. Ryan has held positions at HemoShear Therapeutics since 2010, including Executive Director and Head of Exploratory Biology, where they led the identification and selection of new disease areas for research and development. Ryan has also played a key role in collaboration partnerships with Takeda and Horizon Therapeutics. Prior to their work at HemoShear, Ryan obtained research training grants and fellowships at the University of Virginia and Duke University, focusing on cardiovascular research.

Ryan Feaver attended Duke University from 2001 to 2005, where they earned a Bachelor of Science (BS) degree in Biomedical Engineering. Following their undergraduate studies, they pursued further education at the University of Virginia from 2005 to 2010. During this time, they obtained a Doctor of Philosophy (PhD) degree in Biomedical Engineering.